Cargando…
PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer
Although nuclear type 2C protein phosphatase (PP2Cδ) has been demonstrated to be pro-oncogenic with an important role in tumorigenesis, the underlying mechanisms that link aberrant PP2Cδ levels with cancer development remain elusive. Here, we found that aberrant PP2Cδ activity decreases p53 acetylat...
Autores principales: | Li, Qun, Hao, Qiongyu, Cao, Wei, Li, Jieqing, Wu, Ke, Elshimali, Yahya, Zhu, Donghui, Chen, Qiao-Hong, Chen, Guanglin, Pollack, Jonathan R., Vadgama, Jay, Wu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795508/ https://www.ncbi.nlm.nih.gov/pubmed/31663018 http://dx.doi.org/10.1126/sciadv.aaw8417 |
Ejemplares similares
-
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA
por: Hao, Qiongyu, et al.
Publicado: (2020) -
Protein Lysine Acetylation
by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015) -
Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN
por: Wu, Yanyuan, et al.
Publicado: (2013) -
Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016) -
Celecoxib in breast cancer prevention and therapy
por: Li, Jieqing, et al.
Publicado: (2018)